---
schema_version: "secwatch.filing_event.v1"
accession: "0001808805-22-000059"
form_type: "8-K"
ticker: "NAUT"
cik: "0001808805"
company_name: "Nautilus Biotechnology, Inc."
filed_at: "2022-06-16T23:59:59+00:00"
generated_at: "2026-06-25T01:21:55.584087+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Nautilus Biotechnology stockholders elect three Class I directors and ratify PwC as auditor

## Summary
- Sujal Patel, Vijay Pande, and Michael Altman elected as Class I directors with ~68.5M votes each.
- Broker non-votes of 11,840,796 shares on director election.
- Ratification of PricewaterhouseCoopers as independent auditor: 80.9M for, 31,871 against.
- 81,224,940 shares represented (65.3% of 124,456,653 outstanding shares).

## SEC filing metadata
- accession: 0001808805-22-000059
- form_type: 8-K
- ticker: NAUT
- cik: 0001808805
- company_name: Nautilus Biotechnology, Inc.
- filed_at: 2022-06-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808805/000180880522000059/0001808805-22-000059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808805/000180880522000059/naut-20220614.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001808805-22-000059
- JSON: https://secwatch.observer/filing/0001808805-22-000059.json
- Plain text: https://secwatch.observer/filing/0001808805-22-000059.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.